Human Monoclonal Antibodies for Human ACE2

Twist Human anti-ACE2 Antibodies

Twist Biopharma has developed a set of antibodies that target the extracellular domain (ECD) of the human ACE2 receptor. The ACE2 receptor is known to be the cellular binding target of the SARS-CoV-2 virus, binding of the virus to the ACE2 receptor facilitates viral entry into the cell. The antibody set consists of human antibodies with high affinity to the ACE2 receptor indicating that they have the potential to be used as blocking or competition antibodies for therapeutic applications.